Legumain: A biomarker for diagnosis and prognosis of human ovarian cancer

Journal of Cellular Biochemistry

Volumn 113, Issue 8, 2012, Pages 2679-2686

  Wang, Lina ^a   Chen, Si ^a   Zhang, Mingna ^b   Li, Na ^b   Chen, Yanan ^a   Su, Weijun ^a   Liu, Yanhua ^a   Lu, Dan ^a   Li, Sanglin ^c   Yang, Yixuan ^c   Li, Zongjin ^a   Stupack, Dwayne ^d   Qu, Pengpeng ^b   Hu, Aidong ^c   Xiang, Rong ^a  

^a NANKAI UNIVERSITY   (China)

^b Tianjin Central Hospital for Obstetrics and Gynecology   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biomarker; Isobaric tags for relative and absolute quantification (iTRAQ); Legumain; Ovarian cancer; Prognosis

Indexed keywords

LEGUMAIN;

ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; UPREGULATION;

BLOTTING, WESTERN; CELL MOVEMENT; CYSTEINE ENDOPEPTIDASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84862521462     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24143     Document Type: Article

References (32)

1. Akdogan M, Sasmaz N, Kayhan B, Biyikoglu I, Disibeyaz S, Sahin B. 2001. Extraordinarily elevated CA19-9 in benign conditions: A case report and review of the literature Tumori 87:337-339. (Pubitemid 33116917)
2. Bajjuri KM, Liu Y, Liu C, Sinha SC. 2011. The legumain protease-activated auristatin prodrugs suppress tumor growth and metastasis without toxicity. Chem Med Chem 6:54-59.
3. Banerjee S, Gore M. 2009. The future of targeted therapies in ovarian cancer. Oncologist 14:706-716.
4. Bast RC, Jr., Badgwell D, Lu Z, Marquez R, Rosen D, Liu J, Baggerly KA, Atkinson EN, Skates S, Zhang Z, Lokshin A, Menon U, Jacobs I, Lu K. 2005. New tumor markers: CA125 and beyond. Int J Gynecol Cancer 15(Suppl. 3): 274-281. (Pubitemid 43096594)
5. Brindley PJ, Kalinna BH, Dalton JP, Day SR, Wong JY, Smythe ML, McManus DP. 1997. Proteolytic degradation of host hemoglobin by schistosomes. Mol Biochem Parasitol 89:1-9. (Pubitemid 27373663)
6. Chen JM, Dando PM, Rawlings ND, Brown MA, Young NE, Stevens RA, Hewitt E, Watts C, Barrett AJ. 1997. Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. J Biol Chem 272: 8090-8098. (Pubitemid 27137377)
7. Chen JM, Dando PM, Stevens RA, Fortunato M, Barrett AJ. 1998. Cloning and expression of mouse legumain, a lysosomal endopeptidase. Biochem J 335(Pt. 1):111-117. (Pubitemid 28477056)
8. Dalton JP, Hola-Jamriska L, Brindley PJ. 1995. Asparaginyl endopeptidase activity in adult Schistosoma mansoni. Parasitology 111(Pt. 5):575-580. (Pubitemid 26029502)
9. Fogh J, Fogh JM, Orfeo T. 1977. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59:221-226. (Pubitemid 8144854)
10. Gawenda J, Traub F, Luck HJ, Kreipe H, von Wasielewski R. 2007. Legumain expression as a prognostic factor in breast cancer patients. Breast Cancer Res Treat 102:1-6. (Pubitemid 46294961)
11. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. 1999. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17:994-999. (Pubitemid 29474856)
12. Ishii S. 1993. Asparaginylendopeptidase: An enzyme probably responsible to post-translational proteolysis and transpeptidation of proconcanavalin A. Seikagaku 65:185-189.
13. Itoh Y, Ito A, Iwata K, Tanzawa K, Mori Y, Nagase H. 1998. Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface. J Biol Chem 273:24360-24367. (Pubitemid 28454925)
14. Lau DH, Lewis AD, Ehsan MN, Sikic BI. 1991. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin. Cancer Res 51:5181-5187.
15. Liao D, Liu Z, Wrasidlo W, Chen T, Luo Y, Xiang R, Reisfeld RA. 2011. Synthetic enzyme inhibitor: A novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity. Nanomedicine 7:665-673.
16. Liu C, Sun C, Huang H, Janda K, Edgington T. 2003. Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy. Cancer Res 63:2957-2964. (Pubitemid 36667169)
17. Luo Y, Zhou H, Krueger J, Kaplan C, Lee SH, Dolman C, Markowitz D, Wu W, Liu C, Reisfeld RA, Xiang R. 2006. Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest 116: 2132-2141. (Pubitemid 44162322)
18. Mai J, Finley RL, Jr., Waisman DM, Sloane BF. 2000. Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. J Biol Chem 275:12806-12812. (Pubitemid 30241435)
19. Manoury B, Hewitt EW, Morrice N, Dando PM, Barrett AJ, Watts C. 1998. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature 396:695-699. (Pubitemid 29003950)
20. Manoury B, Gregory WF, Maizels RM, Watts C. 2001. Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing. Curr Biol 11:447-451. (Pubitemid 32241523)
21. Mirgorodskaya OA, Kozmin YP, Titov MI, Korner R, Sonksen CP, Roepstorff P. 2000. Quantitation of peptides and proteins by matrix-assisted laser desorption/ionization mass spectrometry using (18)O-labeled internal standards. Rapid Commun Mass Spectrom 14:1226-1232. (Pubitemid 30489495)
22. Morita Y, Araki H, Sugimoto T, Takeuchi K, Yamane T, Maeda T, Yamamoto Y, Nishi K, Asano M, Shirahama-Noda K, Nishimura M, Uzu T, Hara-Nishimura I, Koya D, Kashiwagi A, Ohkubo I. 2007. Legumain/ asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells. FEBS Lett 581:1417-1424. (Pubitemid 46452617)
23. Murthy RV, Arbman G, Gao J, Roodman GD, Sun XF. 2005. Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer. Clin Cancer Res 11:2293-2299. (Pubitemid 40490189)
24. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M. 2002. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1:376-386.
25. Ross PL, Huang YLN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, Purkayastha S, Juhasz P, Martin S, Bartlet-Jones M, He F, Jacobson A, Pappin DJ. 2004. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3:1154-1169.
26. Sehouli J, Oskay-Ozcelik G. 2009. Current role and future aspects of topotecan in relapsed ovarian cancer. Curr Med Res Opin 25:639-651.
27. van Haaften-Day C, Shen Y, Xu F, Yu Y, Berchuck A, Havrilesky LJ, de Bruijn HW, van der Zee AG, Bast RC, Jr., Hacker NF. 2001. OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: A critical appraisal. Cancer 92:2837-2844. (Pubitemid 33091920)
28. Watts C, Moss CX, Mazzeo D, West MA, Matthews SP, Li DN, Manoury B. 2003. Creation versus destruction of T cell epitopes in the class II MHC pathway. Ann N Y Acad Sci 987:9-14. (Pubitemid 36584002)
29. Yurkovetsky ZR, Linkov FY, DEM, Lokshin AE. 2006. Multiple biomarker panels for early detection of ovarian cancer. Future Oncol 2:733-741. (Pubitemid 44941991)
30. Yurkovetsky Z, Ta'asan S, Skates S, Rand A, Lomakin A, Linkov F, Marrangoni A, Velikokhatnaya L, Winans M, Gorelik E, Maxwell GL, Lu K, Lokshin A. 2007. Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin. Gynecol Oncol 107:58-65. (Pubitemid 47464542)
31. Yurkovetsky Z, Skates S, Lomakin A, Nolen B, Pulsipher T, Modugno F, Marks J, Godwin A, Gorelik E, Jacobs I, Menon U, Lu K, Badgwell D, Bast RC, Jr., Lokshin AE. 2010. Development of a multimarker assay for early detection of ovarian cancer. J Clin Oncol 28:2159-2166.
32. Zhang J, Sui J, Ching CB, Chen WN. 2008. Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2- D LC-MS/MS analysis: Possible action of induced proteins on Alzheimer's disease. Proteomics 8:1595-1607. (Pubitemid 351580206)